Main menu

Advancing clinical metagenomics for patient care in India

  • Published on:

Infectious disease testing is evolving fast, giving researchers the speed and depth they need. This translates into confident decisions and stronger public health surveillance.

In this webinar, Dr Mahua Kapoor (Haystack Analytics) explores how distributed clinical metagenomics can scale across India with insights applicable to healthcare systems worldwide. She shares share practical lessons on integrating next-generation sequencing (NGS) into routine clinical workflows, enabling early and accurate pathogen detection directly from patient samples to close gaps left by conventional microbiology methods.

In this webinar:

  • Discover how targeted NGS enables hypothesis-free, same-day detection of pathogens and antimicrobial resistance genes directly from clinical samples

  • Learn the clinical and economic impact of rapid pathogen identification, including better patient outcomes and lower healthcare costs in low- and middle-income settings

  • Explore how metagenomics delivers real-time, comprehensive workflows with richer insights at scale

Please note: This is independent, investigator-led research using Oxford Nanopore technology. Oxford Nanopore products are for research use only, and not for use in diagnostic procedures.

Authors: Dr Mahua Kapoor, Director Medical Affairs — Infectious Disease (Haystack Analytics) and Harpreet Kukreja, Senior Account Manager, Oxford Nanopore Technologies

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditation
Japanese flag